Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 May;197(2):303-10.

Effects of intermittent and repeated administration of d-amphetamine on restricted water intake in rats

  • PMID: 1271282

Effects of intermittent and repeated administration of d-amphetamine on restricted water intake in rats

R C MacPhail et al. J Pharmacol Exp Ther. 1976 May.

Abstract

Eleven rats had access to water 2 hours daily and intake was measured every 20 minutes. When given intermittently, increasing doses of d-amphetamine (0.05-1.6 mg/rat) decreased total water intake and altered the within-session distribution of intake, with proportionately less intake occurring within early portions of the session after larger doses. Repeated administration of d-amphetamine (0.2, 0.8 or 1.6 mg/rat/day) completely attenuated the overall intake-decreasing effects of the drug; the time taken for recovery of total intake increased with increasing dose. Despite complete tolerance to its overall intake-decreasing effects, d-amphetamine produced persistent dose-related effects on the distribution of intake within sessions that were only partially attenuated with continued daily administration of the drug. Tolerance to the overall intake-decreasing effect of 1.6 mg was accompanied by parallel shifts toward larger doses in the dose-effect functions for total water intake and for the within-session distribution of intake. Redetermination of the dose-effect functions at several times after the repeated administration of 1.6 mg generally showed that tolerance of d-amphetamine was lost within 25 to 57 days after discontinuation of the drug.

PubMed Disclaimer

Publication types

Substances